Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$4.6 - $7.95 $124,048 - $214,387
26,967 New
26,967 $124,000
Q1 2023

May 15, 2023

SELL
$7.31 - $11.18 $1.19 Million - $1.82 Million
-162,896 Reduced 63.01%
95,621 $720,000
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $1.96 Million - $3 Million
206,750 Added 399.39%
258,517 $2.62 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $476,256 - $708,172
51,767 New
51,767 $512,000
Q2 2022

Aug 15, 2022

SELL
$5.72 - $10.65 $854,665 - $1.59 Million
-149,417 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$7.46 - $14.14 $967,890 - $1.83 Million
129,744 Added 659.5%
149,417 $1.46 Million
Q4 2021

Feb 01, 2022

BUY
$12.99 - $17.73 $255,552 - $348,802
19,673 New
19,673 $281,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.